Literature DB >> 22528239

Mapping the Oxford hip score onto the EQ-5D utility index.

Rafael A Pinedo-Villanueva1, David Turner, Andrew Judge, James P Raftery, Nigel K Arden.   

Abstract

PURPOSE: To assess different mapping methods for the estimation of a group's mean EQ-5D score based on responses to the Oxford hip score (OHS) questionnaire.
METHODS: Four models were considered: a) linear regression using total OHS as a continuous regressor; b) linear regression employing responses to the twelve OHS questions as categorical predictors; c) two-part approach combining logistic and linear regression; and d) response mapping. The models were internally validated on the estimation data set, which included OHS and EQ-5D scores for total hip replacements, both before and six months after procedure for 1,759 operations. An external validation was also performed.
RESULTS: All models estimated the mean EQ-5D score within 0.005 of an observed health-state utility estimate, ordinary least squares (OLS) continuous being the most accurate and OLS categorical the most consistent. Age, gender and deprivation did not improve the models. More accurate estimations at the individual level were achieved for higher scores of observed OHS and EQ-5D.
CONCLUSION: Based on these results, when EQ-5D scores are not available, answers to the OHS questionnaire can be used to estimate a group's mean EQ-5D with a high degree of accuracy.

Entities:  

Mesh:

Year:  2012        PMID: 22528239     DOI: 10.1007/s11136-012-0174-y

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  7 in total

Review 1.  Economic evaluation in total hip arthroplasty: analysis and review of the literature.

Authors:  Kevin J Bozic; Khaled J Saleh; Aaron G Rosenberg; Harry E Rubash
Journal:  J Arthroplasty       Date:  2004-02       Impact factor: 4.757

Review 2.  A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures.

Authors:  John E Brazier; Yaling Yang; Aki Tsuchiya; Donna Louise Rowen
Journal:  Eur J Health Econ       Date:  2009-07-08

3.  Questionnaire on the perceptions of patients about total hip replacement.

Authors:  J Dawson; R Fitzpatrick; A Carr; D Murray
Journal:  J Bone Joint Surg Br       Date:  1996-03

4.  The Oxford hip scores for primary and revision hip replacement.

Authors:  R E Field; M D Cronin; P J Singh
Journal:  J Bone Joint Surg Br       Date:  2005-05

5.  Evidence for the validity of a patient-based instrument for assessment of outcome after revision hip replacement.

Authors:  J Dawson; R Fitzpatrick; S Frost; R Gundle; P McLardy-Smith; D Murray
Journal:  J Bone Joint Surg Br       Date:  2001-11

6.  The time trade-off method: results from a general population study.

Authors:  P Dolan; C Gudex; P Kind; A Williams
Journal:  Health Econ       Date:  1996 Mar-Apr       Impact factor: 3.046

7.  Using the health assessment questionnaire to estimate preference-based single indices in patients with rheumatoid arthritis.

Authors:  Nick Bansback; Carlo Marra; Aki Tsuchiya; Aslam Anis; Daphne Guh; Tony Hammond; John Brazier
Journal:  Arthritis Rheum       Date:  2007-08-15
  7 in total
  13 in total

1.  Clinical improvement and satisfaction after total joint replacement: a prospective 12-month evaluation on the patients' perspective.

Authors:  Florian D Naal; Franco M Impellizzeri; Ulrich Lenze; Vanessa Wellauer; Rüdiger von Eisenhart-Rothe; Michael Leunig
Journal:  Qual Life Res       Date:  2015-06-12       Impact factor: 4.147

2.  Mapping CHU9D Utility Scores from the PedsQLTM 4.0 SF-15.

Authors:  Christine Mpundu-Kaambwa; Gang Chen; Remo Russo; Katherine Stevens; Karin Dam Petersen; Julie Ratcliffe
Journal:  Pharmacoeconomics       Date:  2017-04       Impact factor: 4.981

3.  Comparison of pre- and post-operative health-related quality of life and length of stay after primary total hip replacement in matched English and German patient cohorts.

Authors:  Matthias Vogl; Reiner Leidl; Werner Plötz; Nils Gutacker
Journal:  Qual Life Res       Date:  2014-08-15       Impact factor: 4.147

4.  Mapping EQ-5D utility scores from the PedsQL™ generic core scales.

Authors:  Kamran A Khan; Stavros Petrou; Oliver Rivero-Arias; Stephen J Walters; Spencer E Boyle
Journal:  Pharmacoeconomics       Date:  2014-07       Impact factor: 4.981

5.  Mapping Between the Sydney Asthma Quality of Life Questionnaire (AQLQ-S) and Five Multi-Attribute Utility Instruments (MAUIs).

Authors:  Billingsley Kaambwa; Gang Chen; Julie Ratcliffe; Angelo Iezzi; Aimee Maxwell; Jeff Richardson
Journal:  Pharmacoeconomics       Date:  2017-01       Impact factor: 4.981

6.  Predicting EuroQoL 5 Dimensions 5 Levels (EQ-5D-5L) Utilities from Older People's Quality of Life Brief Questionnaire (OPQoL-Brief) Scores.

Authors:  Billingsley Kaambwa; Julie Ratcliffe
Journal:  Patient       Date:  2018-02       Impact factor: 3.883

7.  Mapping the Oxford Shoulder Score onto the EQ-5D utility index.

Authors:  Jonathan L Rees; Rafael Pinedo-Villanueva; Epaminondas M Valsamis; David Beard; Andrew Carr; Gary S Collins; Stephen Brealey; Amar Rangan; Rita Santos; Belen Corbacho
Journal:  Qual Life Res       Date:  2022-09-28       Impact factor: 3.440

8.  Using WOMAC Index scores and personal characteristics to estimate Assessment of Quality of Life utility scores in people with hip and knee joint disease.

Authors:  Ilana N Ackerman; Mark A Tacey; Zanfina Ademi; Megan A Bohensky; Danny Liew; Caroline A Brand
Journal:  Qual Life Res       Date:  2014-03-14       Impact factor: 4.147

9.  Body mass index is not a clinically meaningful predictor of patient reported outcomes of primary hip replacement surgery: prospective cohort study.

Authors:  A Judge; R N Batra; G E Thomas; D Beard; M K Javaid; D W Murray; P A Dieppe; K E Dreinhoefer; K Peter-Guenther; R Field; C Cooper; N K Arden
Journal:  Osteoarthritis Cartilage       Date:  2014-01-11       Impact factor: 6.576

10.  Outcome assessment after hip fracture: is EQ-5D the answer?

Authors:  N Parsons; X L Griffin; J Achten; M L Costa
Journal:  Bone Joint Res       Date:  2014-03-19       Impact factor: 5.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.